Wtree Eur Qual Dvd Grow

French Anti-Fraud Officials Raid Nestle's Perrier Plant Amid Fraud Probe

AstraZeneca and Daiichi Sankyo's Enhertu Approved by FDA for HER2+ Early Breast Cancer

AstraZeneca's Baxfendy Approved in US, Outpacing Mineralys Therapeutics

AstraZeneca and Roche Diagnostics APAC Partner to Develop Advanced Pathology Solutions for Breast and Lung Cancer

Enhertu Approved in US for Two New Indications in HER2+ Early Breast Cancer

Daiichi Sankyo Receives FDA Approval for Enhertu in Early-Stage Breast Cancer, Triggering $155M Milestone Payment from AstraZeneca

JPMorgan and Jefferies Maintain Buy Rating on AstraZeneca, Deutsche Bank Reaffirms Sell

AstraZeneca Late-Stage Trial Shows Imfinzi and enfortumab vedotin Significantly Improve Survival Rates for Muscle-Invasive Bladder Cancer Patients

Owkin Signs Three-Year Licensing Agreement with AstraZeneca to Develop AI Agents

Onco-Innovations and AstraZeneca Partner to Develop AI Models Enhancing Oncology Clinical Outcome Predictions

EMA Approves Baxfendy for Refractory Hypertension

AstraZeneca's ENEBOPARATIDE Meets Primary Endpoint in Phase III Trial

Roche Launches New Blood Test for Alzheimer's Pathology with CE Certification

Roche Signs Final Acquisition Agreement for PathAI

Dapagliflozin Generic Drugs Approved by FDA, Market Enters Full Competition Phase

Benjamin Edwards Inc. Reduces Holdings in Astrazeneca

Bernstein Analyst Reiterates Buy Rating on AstraZeneca with Price Target of 186 Pounds

AstraZeneca's Truqap and Abiraterone Combination Therapy for Prostate Cancer Receives FDA Support

AstraZeneca's Camizestrant Application for Breast Cancer Treatment Split in FDA Vote

Bernstein Downgrades AstraZeneca Target Price

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

Silexion Therapeutics

Bristol-Myers Squibb Company

MetaVia

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

EUDG

The European Equity Fund will hold its annual shareholder meeting in New York on June 30, 2026. Shareholders will vote to elect two directors, Bernhard Koepp and Wolfgang Leoni, and ratify Ernst & Young as the independent auditor for the fiscal year ending December 31, 2026.

PUBT

European Equity Fund

European Equity Fund announces annual shareholder meeting

IEUR

Planned investment for the next three years is falling even as AI cements its role as a crucial economic driver. View on euronews

ishares Core Msci Europe

VG Ftse Eur

European companies are reindustrialising — just with less money

A recent Atradius survey reveals that nearly 80% of companies in Western Europe are experiencing late payments, with trade credit now accounting for 52% of B2B transactions. This shift is attributed to restricted bank financing and rising input costs due to inflation and geopolitical tensions. Many businesses report reduced cash flow and increased reliance on costly external finance. Looking ahead, over half of the companies do not anticipate improvements in payment behavior, indicating a fragile business confidence.

MorningStar

Nearly four in five companies in Western Europe faced with late payments, Atradius survey finds

European stocks fell on Friday due to ongoing tensions between the U.S. and Iran, with little progress in de-escalating the Middle East conflict. The closure of the Strait of Hormuz has kept oil prices high, raising concerns about the persistence of these tensions.

rttnews

European Shares Retreat Amid Tensions Over Hormuz

European stocks faced uncertainty on Wednesday as investors assessed mixed earnings reports and prepared for upcoming in-person negotiations between the United States and Iran, anticipated to occur this weekend. The U.S. has introduced two new conditions for resuming talks.

ISHRS S&P Eu 350

European Shares Struggle For Direction As Investors Weigh Earnings

CURE

The EU's pharma exports rose 16% in 2025, totaling €366.2bn, marking a record trade surplus of €220.5bn. However, analysts warn of potential "frontloading" effects, suggesting weaker growth in 2026 due to US tariffs and geopolitical uncertainties. Ireland led EU exports, followed by Germany and Belgium, with the US receiving 44% of total exports. Despite challenges, the EU aims to enhance its pharma competitiveness against the US and China, with new initiatives and investments in the sector.

Pharmaceutical Technology

Direxion Healthcare Bull 3X

EU sees 2025 pharma export uptick amid competitiveness concerns

Hungary's election resulted in a significant political shift as Prime Minister Viktor Orbán conceded defeat to the pro-EU Tisza party, led by Péter Magyar. This outcome, marked by a record turnout of 78%, signals a demand for change amid economic stagnation and corruption. The election is seen as euro-positive due to reduced political fragmentation within the EU, increased likelihood of unlocking EU funds, and a geopolitical pivot back toward EU alignment, potentially reopening the path to euro adoption. Overall, the election supports improved EU cohesion and a more stable policy environment for the euro.

Investinglive

SPDR EURO STOXX 50 ETF

Pro Ultrshort Euro

iShares MSCI Eurozone

Pro Ultr Euro

Currencyshares Euro Trust

EU politics - Orban lost the Hungarian election. Landslide opposition win. EUR impact.

ISFD

Germany's DAX 30 index initially closed down 1.61% at 23698.47 points. The French stock index initially closed down 0.80%, the Italian stock index initially closed up 0.16% with the banking index down 0.76%, and the UK stock index initially closed down 0.44%

Wallstreetcn

iShares PLC - iShares Core FTSE 100 UCITS ETF Accum Hedged USD

Amundi ETF DAX UCITS ETF (DR) FCP

ISHRS MSCI Italy Capped

iShares Core FTSE 100 UCITS ETF GBP (Dist)

Deutsche Bank AG

Legal & General Group Plc

Global X DAX Germany ETF

iShares Core FTSE 100 UCITS ETF GBP (Acc)

iShares EURO STOXX Mid UCITS ETF

iShares EURO STOXX 50 UCITS ETF (Acc) EUR

Lyxor FTSE 100 UCITS ETF

Huaan France CAC40 ETF(QDII)

RBS Market Access SICAV - RBS Market Access Leveraged FTSE MIB Monthly Index ETF Capitalisation

iShares Core MSCI Europe UCITS ETF EUR (Acc)

HSBC FTSE 100 UCITS ETF

Vanguard FTSE 100 UCITS ETF

Xtrackers DAX Income UCITS ETF

RBS Market Access SICAV - RBS Market Access Short FTSE MIB Monthly Index ETF Capitalisation

L5EW

The Iran war has significantly impacted European ETF flows, which dropped to €9.4bn in March from €45.4bn in February. Despite a record high of €101.7bn in Q1, investor caution increased due to geopolitical tensions. Energy ETFs saw inflows of €1.7bn, while financial services equity ETFs faced €3.7bn in outflows. Bond ETFs also reported €2.4bn in outflows, reversing previous gains, as recession fears grew. Overall, investors prioritized liquidity amid market volatility, with selective interest in energy sectors.

cityam

Ossiam Euro STOXX 50 Equal Weight NR UCITS ETF -1C-EUR

Iran war sparks sharp reversal in European ETF rally

The European Equity Fund (NYSE:EEA) stock price has fallen below its 200-day moving average of $10.66, trading as low as $9.80. Currently, it trades at $9.9850 with a volume of 111,137 shares. Institutional investors hold 51.94% of the stock, with recent acquisitions from firms like Wolverine Asset Management and Citadel Advisors. Analysts rate the stock as a Hold, but suggest other stocks may be better investments.

Market Beat

Fidelity European Trust PLC GBP

The European Equity Fund (NYSE:EEA) Stock Price Crosses Below 200 Day Moving Average   - What's Next?

Wtree Eur Qual Dvd Grow(EUDG.US)